Triple
T19331800
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Fosun Pharma |
E483513
|
entity |
| Predicate | hasSubsidiary |
P254
|
FINISHED |
| Object | Jiangsu Wanbang Biopharmaceuticals |
—
|
NE NERFINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Jiangsu Wanbang Biopharmaceuticals | Statement: [Fosun Pharma, hasSubsidiary, Jiangsu Wanbang Biopharmaceuticals]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Jiangsu Wanbang Biopharmaceuticals Context triple: [Fosun Pharma, hasSubsidiary, Jiangsu Wanbang Biopharmaceuticals]
-
A.
Fosun Pharma
Fosun Pharma is a major Chinese pharmaceutical and healthcare company engaged in the research, development, manufacturing, and distribution of a wide range of medical products and services.
-
B.
Sinopharm
Sinopharm is a Chinese state-owned pharmaceutical company best known globally for developing and distributing inactivated COVID-19 vaccines.
-
C.
Fosun International
Fosun International is a major Chinese multinational conglomerate with diversified investments spanning sectors such as finance, healthcare, tourism, and consumer products.
-
D.
Shanghai Jiushi Group
Shanghai Jiushi Group is a major state-owned enterprise in Shanghai involved in urban infrastructure, transportation, and sports and cultural event operations.
-
E.
Jianghuai Guanhua
Jianghuai Guanhua is a major variety of Mandarin Chinese spoken primarily in parts of Jiangsu and Anhui provinces, characterized by distinctive phonological and lexical features.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Jiangsu Wanbang Biopharmaceuticals Target entity description: Jiangsu Wanbang Biopharmaceuticals is a Chinese pharmaceutical company known for developing and manufacturing drugs, particularly in areas such as endocrinology and chronic disease treatment.
-
A.
Fosun Pharma
Fosun Pharma is a major Chinese pharmaceutical and healthcare company engaged in the research, development, manufacturing, and distribution of a wide range of medical products and services.
-
B.
Sinopharm
Sinopharm is a Chinese state-owned pharmaceutical company best known globally for developing and distributing inactivated COVID-19 vaccines.
-
C.
Fosun International
Fosun International is a major Chinese multinational conglomerate with diversified investments spanning sectors such as finance, healthcare, tourism, and consumer products.
-
D.
Shanghai Jiushi Group
Shanghai Jiushi Group is a major state-owned enterprise in Shanghai involved in urban infrastructure, transportation, and sports and cultural event operations.
-
E.
Jianghuai Guanhua
Jianghuai Guanhua is a major variety of Mandarin Chinese spoken primarily in parts of Jiangsu and Anhui provinces, characterized by distinctive phonological and lexical features.
- F. None of above. chosen
Provenance (2 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d8e8d13e3c81909d91d1d5ec37c095 |
completed | April 10, 2026, 12:10 p.m. |
| NER | Named-entity recognition | batch_69e616422fa08190bf4bde4312ec7cf3 |
completed | April 20, 2026, 12:04 p.m. |
Created at: April 10, 2026, 1:33 p.m.